中文
English
About Us
Company
Team
Honor
Vision & Mission
Contact Us
Pipeline
Innovation
Biosimilar
R & D
Antibody Screening
Pharmacodynamics
Protein/Ab Engineering
Process Dev
Multi-functional Fc platform
While the specificity of mAbs are fully appreciated, at the early days, scien...
In vitro/In vivo Pharmaco...
In vitro/In vivo Pharmacology Evaluation Platform in Alphamab including cell b...
Manufacturing
Pilot Production
Quality System
Partnering
Opportunities
Corporation
Academic
News
Press Release
Worth to be Noted
Career
Career opportunity
Apply On-line
News
Press Release
Worth to be Noted
---- Useful Link ----
Alphamab Jilin
DingFu Biotarget
Shihuida Pharma
CFDA
CDE
NIFDC
Press Release
Home
>
News
>
Press Release
KN035 (Envafolimab) Phase IIb HBV Clinical Trial initiated
Learn More
Press Release
Events
Date
KN015临床申报现场核查顺利完成
2014-04-09
徐霆博士于第二届创新创业大赛中进入总决赛并取得第三名
2013-08-27
total7Record,total2Page,Current2Page
Home Page
Pre
Next
End
Home
|
About Us
|
Pipeline
|
R & D
|
Manufacturing
|
Partnering
|
News
|
Career